pyrazolanthrone has been researched along with panobinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, M; Xie, H; Xu, M | 1 |
1 other study(ies) available for pyrazolanthrone and panobinostat
Article | Year |
---|---|
Histone deacetylase inhibitors induce human renal cell carcinoma cell apoptosis through p-JNK activation.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Renal Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; MAP Kinase Signaling System; Panobinostat; Phosphorylation; Proto-Oncogene Proteins c-bcl-2 | 2013 |